Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Aug 20, 2006 8:29pm
185 Views
Post# 11249834

RE: A little history / barcodewhiz

RE: A little history / barcodewhizBalain, I completely agree that a courtcase is a shiitty way to start a relationship... but we cant change what's already happened. But Melnyk is a proven winner and he drives a hard bargain... because he can. The court case is the result of that, the way I understand it. My point was simple.... I believe the arbitration is going to bring a decisive resolution of this issue. From what I gather, we will get a ruling from the judge within 2 weeks. I was simply making the point that ALMOST any result will be positive for Prometic, as long as we get a definitive resolution. Melnyk is not dumb... he knows he needs Prometic and its technology in order to succeed at building Hemosol... As soon as this arbitration is done, everyone shakes hands like businessmen and start working as a team... because everybody wins. I think the market is underestimating this potential.... ( with good reason because we have had so many failures and false starts ) BUT... if Melnyk really has big intentions to fund and drive Hemosol agressively forward... then this has good implications for Prometic and its technology.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse